These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24713322

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.
    Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A.
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [Abstract] [Full Text] [Related]

  • 6. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA.
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [Abstract] [Full Text] [Related]

  • 7. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    De Pascalis R, Hahn A, Brook HM, Ryden P, Donart N, Mittereder L, Frey B, Wu TH, Elkins KL.
    PLoS One; 2018 Oct; 13(5):e0198140. PubMed ID: 29799870
    [Abstract] [Full Text] [Related]

  • 8. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 9. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May 22; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 10. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.
    Jia Q, Horwitz MA.
    Front Cell Infect Microbiol; 2018 May 22; 8():154. PubMed ID: 29868510
    [Abstract] [Full Text] [Related]

  • 11. Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.
    De Pascalis R, Mittereder L, Chou AY, Kennett NJ, Elkins KL.
    PLoS One; 2015 May 22; 10(5):e0126570. PubMed ID: 25973794
    [Abstract] [Full Text] [Related]

  • 12. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 13. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
    Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP.
    Clin Vaccine Immunol; 2009 Apr 31; 16(4):444-52. PubMed ID: 19211773
    [Abstract] [Full Text] [Related]

  • 14. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.
    PLoS One; 2013 Apr 31; 8(4):e61539. PubMed ID: 23613871
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.
    Vaccine; 2009 Sep 18; 27(41):5554-61. PubMed ID: 19651173
    [Abstract] [Full Text] [Related]

  • 16. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA.
    Infect Immun; 2013 May 18; 81(5):1550-61. PubMed ID: 23439306
    [Abstract] [Full Text] [Related]

  • 17. T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.
    Collazo CM, Meierovics AI, De Pascalis R, Wu TH, Lyons CR, Elkins KL.
    Infect Immun; 2009 May 18; 77(5):2010-21. PubMed ID: 19237526
    [Abstract] [Full Text] [Related]

  • 18. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W, Shen H, Webb A, KuoLee R, Conlan JW.
    Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099
    [Abstract] [Full Text] [Related]

  • 19. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
    Melillo AA, Foreman O, Bosio CM, Elkins KL.
    Infect Immun; 2014 Apr 08; 82(4):1477-90. PubMed ID: 24421047
    [Abstract] [Full Text] [Related]

  • 20. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
    Sanapala S, Yu JJ, Murthy AK, Li W, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.
    Infect Immun; 2012 Jun 08; 80(6):2177-85. PubMed ID: 22493083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.